| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |